| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 02/03/2011 | WO2011013624A1 Indole derivative and pharmacologically acceptable salt thereof |
| 02/03/2011 | WO2011013623A1 Indole derivative and pharmacologically acceptable salt thereof |
| 02/03/2011 | WO2011012862A1 Herbicidally active heteroaryl-sυbstitυted cyclic diones or derivatives thereof |
| 02/03/2011 | WO2011012674A1 Dihydrobenzoindazoles |
| 02/03/2011 | WO2010131192A3 Novel oxazolidinone derivatives and their use as orexin receptor antagonists |
| 02/03/2011 | WO2010115491A3 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 02/03/2011 | US20110028514 Azoles as Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 02/03/2011 | US20110028493 Heterocyclic derivative and use thereof |
| 02/03/2011 | US20110028486 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7 |
| 02/03/2011 | US20110028482 Isoxazolines as inhibitors of fatty acid amide hydrolase |
| 02/03/2011 | US20110028481 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/03/2011 | US20110028476 Proton pump inhibitors |
| 02/03/2011 | US20110028468 Compounds having npy y5 receptor antagonistic activity |
| 02/03/2011 | US20110028461 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/03/2011 | US20110028451 Dihydrobenzoindazoles |
| 02/03/2011 | US20110028447 Indazole derivatives |
| 02/03/2011 | US20110028446 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 02/03/2011 | US20110028433 Quinazolinone derivatives as tubulin polymerization inhibitors |
| 02/03/2011 | US20110028320 Compositions and methods for controlling nematodes |
| 02/03/2011 | US20110027716 Actinic-ray- or radiation-sensitive resin composition, compound and method of forming pattern using the composition |
| 02/03/2011 | US20110027178 Imaging the central nervous system |
| 02/03/2011 | CA2768904A1 Dihydrobenzoindazoles |
| 02/03/2011 | CA2768816A1 Indole derivative or pharmaceutically acceptable salt thereof |
| 02/03/2011 | CA2768814A1 Indole derivative or pharmaceutically acceptable salt thereof |
| 02/03/2011 | CA2768596A1 Herbicidally active heteroaryl-substituted cyclic diones or derivatives thereof |
| 02/03/2011 | CA2768232A1 Substituted benzamide derivatives as glucokinase (gk) activators |
| 02/03/2011 | CA2767083A1 Bicyclic compound and use thereof for medical purposes |
| 02/03/2011 | CA2766515A1 Compounds for the reduction of .beta.-amyloid production |
| 02/02/2011 | EP2280014A2 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 02/02/2011 | EP2280003A2 Process for preparing receptor-type kinase modulators |
| 02/02/2011 | EP2279029A2 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
| 02/02/2011 | EP2278969A2 Inhibitors of janus kinases |
| 02/02/2011 | EP2089369B1 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 02/02/2011 | EP1485358B1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
| 02/02/2011 | CN1838953B 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
| 02/02/2011 | CN101965346A Novel pyrimidine-pyridine derivatives |
| 02/02/2011 | CN101965343A 2-aza-bicyclo[2.2.1]heptane derivatives |
| 02/02/2011 | CN101965339A Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 02/02/2011 | CN101962380A Novel organic conjugated molecule and application thereof to organic solar cell |
| 02/02/2011 | CN101961333A A thiazolidinedione derivative and its use as antidiabetic |
| 02/02/2011 | CN101213193B Mono-lysine salts of azole compounds |
| 02/01/2011 | US7880013 such as N-[4-(2-Furyl)-5-(4-pyridyl)thiazol-2-yl]pyridine-4-carboxamide, havu=ing adenosine receptor antagonistic activity, used for treating Parkinson's disease, Alzheimer's disease, creutfildt-jacob disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington's chorea, atrophy and ischemia |
| 02/01/2011 | US7880009 Cinnamide compound |
| 02/01/2011 | US7880008 Heterocycles useful as modulators of ion channels |
| 02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |
| 02/01/2011 | US7879889 Therapeutic use of acylaminothiazole derivatives |
| 02/01/2011 | US7879886 such as N-benzyl-N-hydroxy-2-(3-hydoxypyridin-2-ene)-1,3-thiazolidine-4-carboxamide, used for reducing the population of Plasmodium in a human infested with Plasmodium protozoans and suffering from malaria |
| 02/01/2011 | US7879882 Thiazolyl mglur5 antagonists and methods for their use |
| 02/01/2011 | US7879881 Piperidinyl compounds that selectively bind integrins |
| 02/01/2011 | US7879854 2-morpholin-4-ylethyl 5-[3-[(2S)-1-[4-(1-hydroxyhexyl)phenyl]-5-oxopyrrolidin-2-yl]propyl]thiophene-2-carboxylate, useful in treating vision defects, inflammatory bowel disease and alopecia |
| 02/01/2011 | US7879851 Viral polymerase inhibitors |
| 02/01/2011 | US7879850 Organic compounds |
| 02/01/2011 | CA2630040C Heterocycle-substituted 3-alkyl azetidine derivatives |
| 02/01/2011 | CA2551529C Amide derivative and medicine |
| 02/01/2011 | CA2481055C Combinations of quinolinone derivatives and 5-fu or cpt 11 |
| 02/01/2011 | CA2477931C O-cyclopropyl-carboxanilides and their use as fungicides |
| 02/01/2011 | CA2466140C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 02/01/2011 | CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 02/01/2011 | CA2453747C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use |
| 02/01/2011 | CA2442917C Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 02/01/2011 | CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas |
| 01/27/2011 | WO2011011522A2 Potent small molecule inhibitors of autophagy, and methods of use thereof |
| 01/27/2011 | WO2011011303A1 Inhibitors of flaviviridae viruses |
| 01/27/2011 | WO2011010222A1 Novel pyrazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 01/27/2011 | WO2011009943A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders |
| 01/27/2011 | WO2011009226A1 Preparation method of dasatinib derivatives useful as antitumor agents and their intermediates |
| 01/27/2011 | WO2010118063A3 Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use |
| 01/27/2011 | WO2010105048A9 Thiazolidinedione analogues |
| 01/27/2011 | WO2010029458A3 A process for preparing quetiapine fumarate |
| 01/27/2011 | US20110021771 Inhibitors of histone deacetylase |
| 01/27/2011 | US20110021582 Benzophenone thiazole derivatives useful for inhibiting formation of microtubule and method for producing the same |
| 01/27/2011 | US20110021576 Novel process to prepare pioglitazone via several novel intermediates |
| 01/27/2011 | US20110021559 Aminopyridines useful as inhibitors of protein kinases |
| 01/27/2011 | US20110021549 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 01/27/2011 | US20110021528 Novel hydroxamates as therapeutic agents |
| 01/27/2011 | US20110021495 Quinazoles useful as modulators of ion channels |
| 01/27/2011 | US20110021489 Substituted piperidines |
| 01/27/2011 | US20110021487 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use |
| 01/27/2011 | US20110021486 Viral polymerase inhibitors |
| 01/27/2011 | US20110021462 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 01/27/2011 | US20110020278 Inhibitors of flaviviridae viruses |
| 01/27/2011 | CA2768980A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders |
| 01/27/2011 | CA2768832A1 Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators |
| 01/27/2011 | CA2767772A1 Potent small molecule inhibitors of autophagy, and methods of use thereof |
| 01/27/2011 | CA2767088A1 Inhibitors of flaviviridae viruses |
| 01/26/2011 | EP2277879A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 01/26/2011 | EP2277867A2 Compounds, pharmaceutical compositions thereof and their use in treating cancer |
| 01/26/2011 | EP2276761A1 Carboxamide compounds for the treatment of metabolic disorders |
| 01/26/2011 | EP2276760A1 Fused ring compounds and use thereof |
| 01/26/2011 | EP2276759A1 3-indazolyl-4-pyridylisothiazoles |
| 01/26/2011 | EP2276756A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/26/2011 | EP2276747A1 Sulfonamides as zap-70 inhibitors |
| 01/26/2011 | EP2276746A1 Substituted pyridazinylmethyl sulfonamides |
| 01/26/2011 | EP2276730A2 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 01/26/2011 | EP2155740B1 Hetarylanilines as modulators for amyloid beta |
| 01/26/2011 | EP2144894B1 Oxime ester photoinitiators |
| 01/26/2011 | EP2094663B1 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 01/26/2011 | EP2041125B1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
| 01/26/2011 | EP1973888B1 Isoxazolines for controlling invertebrate pests |